全文获取类型
收费全文 | 1288篇 |
免费 | 92篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 10篇 |
妇产科学 | 8篇 |
基础医学 | 81篇 |
口腔科学 | 10篇 |
临床医学 | 109篇 |
内科学 | 71篇 |
皮肤病学 | 4篇 |
神经病学 | 453篇 |
特种医学 | 6篇 |
外科学 | 34篇 |
综合类 | 25篇 |
预防医学 | 31篇 |
眼科学 | 2篇 |
药学 | 517篇 |
中国医学 | 8篇 |
肿瘤学 | 19篇 |
出版年
2023年 | 10篇 |
2022年 | 14篇 |
2021年 | 20篇 |
2020年 | 34篇 |
2019年 | 43篇 |
2018年 | 36篇 |
2017年 | 48篇 |
2016年 | 32篇 |
2015年 | 43篇 |
2014年 | 50篇 |
2013年 | 164篇 |
2012年 | 58篇 |
2011年 | 52篇 |
2010年 | 46篇 |
2009年 | 42篇 |
2008年 | 55篇 |
2007年 | 38篇 |
2006年 | 41篇 |
2005年 | 38篇 |
2004年 | 40篇 |
2003年 | 42篇 |
2002年 | 39篇 |
2001年 | 35篇 |
2000年 | 23篇 |
1999年 | 13篇 |
1998年 | 7篇 |
1997年 | 13篇 |
1996年 | 7篇 |
1995年 | 14篇 |
1994年 | 7篇 |
1993年 | 11篇 |
1992年 | 14篇 |
1991年 | 15篇 |
1990年 | 7篇 |
1989年 | 7篇 |
1988年 | 7篇 |
1987年 | 15篇 |
1986年 | 19篇 |
1985年 | 29篇 |
1984年 | 19篇 |
1983年 | 25篇 |
1982年 | 27篇 |
1981年 | 15篇 |
1980年 | 17篇 |
1979年 | 16篇 |
1978年 | 8篇 |
1977年 | 9篇 |
1976年 | 8篇 |
1974年 | 6篇 |
1973年 | 5篇 |
排序方式: 共有1389条查询结果,搜索用时 19 毫秒
1.
Ana Paula Valverde erson Camargo Ana L cia S Rodrigues 《World Journal of Psychiatry》2021,11(11):981-996
Major depressive disorder (MDD) is a disabling and highly prevalent mood disorder as well as a common cause of suicide. Chronic stress, inflammation, and intestinal dysbiosis have all been shown to play crucial roles in the patho physiology of MDD. Although conventional antidepressants are widely used in the clinic, they can take weeks to months to produce therapeutic effects. The discovery that ketamine promotes fast and sustaining antidepressant responses is one of the most important breakthroughs in the pharmacotherapy of MDD. However, the adverse psychomimetic/dissociative and neurotoxic effects of ketamine discourage its chronic use. Therefore, agmatine, an endogenous glutamatergic modulator, has been postulated to elicit fast behavioral and synaptogenic effects by stimulating the mechanistic target of rapamycin complex 1 signaling pathway, similar to ketamine. However, recent evidence has demonstrated that the modulation of the NLR family pyrin domain containing 3 inflammasome and gut microbiota, which have been shown to play a crucial role in the pathophysiology of MDD, may also participate in the antidepressant-like effects of both ketamine and agmatine. This review seeks to provide evidence about the mechanisms that may underlie the fast antidepressant-like responses of agmatine in preclinical studies. Considering the anti-inflammatory properties of agmatine, it may also be further investigated as a useful compound for the management of MDD associated with a pro-inflammatory state. Moreover, the fast antidepressant-like response of agmatine noted in animal models should be investigated in clinical studies. 相似文献
2.
3.
4.
5.
Gal Shoval Ran D. Balicer Becca Feldman Moshe Hoshen Gilad Eger Abraham Weizman Gil Zalsman Brendon Stubbs Pavel Golubchik Barak Gordon Amir Krivoy 《Depression and anxiety》2019,36(10):921-929
Background: Depression and anxiety are common in cancer and antidepressants (AD) are efficacious treatment. The relationship between AD adherence and mortality in cancer is unclear. This study aimed to evaluate the association between adherence to AD and all‐cause mortality in a population‐based cohort of patients with cancer. Materials and Methods: We conducted a 4‐year historical prospective cohort study including 42,075 patients with cancer who purchased AD at least once during the study period. Adherence to AD was modeled as nonadherence (<20%), poor (20–50%), moderate (50–80%), and good (>80%) adherence. We conducted multivariable survival analyses adjusted for demographic and clinical variables that may affect mortality. Results: During 1,051,489 person‐years at risk follow‐up, the adjusted hazard ratios (HR) for mortality were 0.89 (95% confidence interval [CI]: 0.83–0.95), 0.77 (95% CI: 0.66–0.72), and 0.80 (95% CI: 0.76–0.85) for the poor, moderate, and good adherence groups, respectively, compared to the nonadherent group. Analysis of the entire sample and a subgroup with depression, for cancer subtypes, revealed similar patterns for breast, colon, lung, and prostate cancers, but not for melanoma patients. Multivariate predictors of premature mortality included male gender (HR 1.48 [95% CI: 1.42–1.55]), current/past smoking status (HR 1.1, [95% CI: 1.04–1.15]; P < .0001), low socioeconomic status (HR 1.1, [95% CI: 1.03–1.17]; P < .0001) and more physical comorbidities. Conclusions: The present study is the first to demonstrate that higher adherence to AD is associated with a decrease of all‐cause mortality in a large nationwide cohort of cancer patients. Our data add to the pressing need to encourage adherence to AD among cancer patients. 相似文献
6.
袁心崧 《复旦学报(医学版)》2019,46(3):414-419
在第2周未达到早期改善(early improvement)的重度抑郁症(major depressive disorder,MDD)患者继续维持原治疗方案只有3%能达到临床治愈,但尽管早期改善有较高的阴性预测值,阳性预测值却不理想。本综述整理现有的研究中除了17项汉密尔顿抑郁量表总分的减分率外,还有哪些指标能判断早期改善,早期改善的预测效果受到什么因素影响,能否协同这些因素提高早期改善的预测效果。用以指导早期换药,降低患者接受无效治疗的时间,降低治疗费用,增加患者对治疗的信心。 相似文献
7.
Antidepressant and antipsychotic drugs are regularly encountered in different aspects of forensic toxicology, and some cases require the examination of hair samples. In this study, common antidepressant and antipsychotic drugs regarding hair concentrations over the past decades were reviewed. Although numerous publications around method validations, case reports, or controlled dose studies were found, apparently there is a lack of comprehensive data for many substances. Information on the hair length and dosage across the publications varied largely, and case numbers were generally low except for several retrospective controlled dose studies. Many substances were described only in method validations or case reports, and data were obtained from small case numbers. On the contrary, clozapine, haloperidol, amitriptyline, nortriptyline, risperidone and its metabolite, methylphenidate, citalopram, chlorpromazine, chlorprothixene, and quetiapine had a well‐founded database as these substances were investigated in controlled dose studies with higher case numbers. Given the advancements made in analytical techniques over the past years, gas chromatography–mass spectrometry and liquid chromatography with tandem mass spectrometry techniques were the methods of choice and allowed the detection of chemical compounds at low concentrations. The controversy around a potential use of hair analysis to estimate the dosage remains as dose‐concentration studies provided divergent results. A harmonization on the investigated hair length as well as on the extraction protocol would be of favor to achieve better comparability. Although hair analysis research focused mainly on drug abuse, availability of more data on antidepressants and antipsychotics would help to gain better knowledge and assist other forensic investigators. 相似文献
8.
焦虑是一种带有恐惧成分的强烈行为和心理反应,抑郁是一种以心境的高涨或低落为主的精神障碍,两种症状均伴有认知和行为的改变,是心脏病患者常见的共患病。心脏手术是引发患者特定情绪和生理反应的重要因素之一,术后持续或首发的抑郁和焦虑不仅会增加手术并发症、近期或远期的死亡率和医疗费用等,还会严重影响患者的社会功能和生活质量。随着生物-心理-社会医学模式的转变,对心脏手术患者进行围术期的心理状态和生物学风险评估必不可少。本文对心脏手术患者焦虑和抑郁的特点、相关机制及治疗干预等进行综述。 相似文献
9.
Lone Baandrup 《Basic & clinical pharmacology & toxicology》2020,126(3):183-192
Schizophrenia is a severe mental disorder characterized by a heterogeneous symptom profile which comprises a clinical platform for widespread use of polypharmacy even though antipsychotic monotherapy is the recommended treatment regimen. This narrative review provides a summary of the current gap between evidence and practice for use of antipsychotic combination therapy in patients with schizophrenia. Antipsychotic polypharmacy is frequently prescribed instead of following international consensus of clozapine monotherapy in treatment‐resistant patients. Antipsychotic‐benzodiazepine combination therapy clearly has a role in the treatment of acute agitation whereas there is no evidence to support an effect on core schizophrenia symptoms when chronically prescribed. Antidepressants are typically added to antipsychotic treatment in case of persistent negative symptoms. Available evidence suggests that antidepressants may improve negative symptom control in schizophrenia. Combining an antipsychotic with an antiepileptic is not supported by any firm evidence, but individual mood stabilizers have come out positively in single trials. Generally, the evidence base for polypharmacy in schizophrenia maintenance treatment is sparse but may be warranted in certain clinical situations. Therapeutic benefits and side effects should be carefully monitored and considered to ensure a beneficial risk‐benefit ratio if prescribing polypharmacy for specific clinical indications. 相似文献
10.